Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 4,110 INR
Change Today -177.35 / -4.14%
Volume 48.7K
SANL On Other Exchanges
Natl India
As of 7:06 AM 08/3/15 All times are local (Market data is delayed by at least 15 minutes).

sanofi india ltd (SANL) Snapshot

Previous Close
Day High
Day Low
52 Week High
08/3/15 - 4,581
52 Week Low
08/11/14 - 2,722
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SANOFI INDIA LTD (SANL)

Related News

No related news articles were found.

sanofi india ltd (SANL) Related Businessweek News

No Related Businessweek News Found

sanofi india ltd (SANL) Details

Sanofi India Limited manufactures and sells pharmaceutical products in India and internationally. It provides medicines for the treatment of patients in various therapeutic areas, such as cardiovascular diseases, thrombosis, diabetes, oncology, respiratory system, central nervous system, dermatology, analgesics, anti-infectives, bone and joint, gastrointestinal disorders, and consumer healthcare. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was founded in 1956 and is based in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH.

3,448 Employees
Last Reported Date: 03/9/15
Founded in 1956

sanofi india ltd (SANL) Top Compensated Officers

Managing Director, Vice President of South As...
Total Annual Compensation: 8.9M
Chief Financial Officer, Whole-Time Director,...
Total Annual Compensation: 6.1M
Compensation as of Fiscal Year 2014.

sanofi india ltd (SANL) Key Developments

Sanofi India Limited Announces Unaudited Earnings Results for the First Quarter Ended March 31, 2015; Approves Final and Special Dividend for the Year Ended December 31, 2014 Payable on May 8, 2015

Sanofi India Limited announced unaudited earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported net sales of INR 4,598 million against INR 4,199 million a year ago. Profit from continuing operations before other income and finance costs and exceptional items was INR 570 million against INR 570 million a year ago. Net profit after exceptional items was INR 484 million against INR 517 million a year ago. Net profit after exceptional items was INR 645 million against INR 517 million a year ago. Basic and diluted earnings per share before and after exceptional items were INR 28.04 against INR 22.48 a year ago. The company announced that the annual general meeting held on April 29, 2015, approved a final dividend of INR 24 per Equity share for the year ended December 31, 2014. The dividend will be paid on May 8, 2015. The company also approved special one-time dividend of INR 11 per Equity share of INR 10 for the year ended December 31, 2014.

Sanofi India Limited to Report Q1, 2015 Results on Apr 29, 2015

Sanofi India Limited announced that they will report Q1, 2015 results on Apr 29, 2015

Sanofi India Limited, Board Meeting, Apr 29, 2015

Sanofi India Limited, Board Meeting, Apr 29, 2015. Agenda: To approve the unaudited financial results for the first quarter ended March 31, 2015.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SANL:IN 4,110.00 INR -177.35

SANL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott India Ltd 4,501 INR +41.80
Cadila Healthcare Ltd 1,852 INR -34.60
Medivation Inc $104.78 USD -0.55
Pfizer Ltd/India 2,293 INR +117.00
Piramal Enterprises Ltd 901.05 INR -19.15
View Industry Companies

Industry Analysis


Industry Average

Valuation SANL Industry Range
Price/Earnings 49.1x
Price/Sales 4.8x
Price/Book 6.3x
Price/Cash Flow 25.5x
TEV/Sales 4.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SANOFI INDIA LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at